Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

Deborah F. King; Helen Groves; Charlie Weller; Ian Jones; Jakob P. Cramer; Peter B. Gilbert; David Goldblatt; Marion F. Gruber; Beate Kampmann; Diadié Maïga; Marcela F. Pasetti; Stanley A. Plotkin; Alexander Precioso; Liya Wassie; Frederick Wittke; David C. Kaslow

doi:10.1038/s41541-024-00872-6

npj Vaccines (Apr 2024)

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

Deborah F. King,
Helen Groves,
Charlie Weller,
Ian Jones,
Jakob P. Cramer,
Peter B. Gilbert,
David Goldblatt,
Marion F. Gruber,
Beate Kampmann,
Diadié Maïga,
Marcela F. Pasetti,
Stanley A. Plotkin,
Alexander Precioso,
Liya Wassie,
Frederick Wittke,
David C. Kaslow

Affiliations

Deborah F. King: Wellcome
Helen Groves: Wellcome
Charlie Weller: Wellcome
Ian Jones: WHO consultant, Jinja Publishing Ltd
Jakob P. Cramer: Coalition for Epidemic Preparedness Innovations (CEPI)
Peter B. Gilbert: Vaccine Infectious Disease Division, Fred Hutchinson Cancer Center
David Goldblatt: Great Ormond Street Institute of Child Health, University College London
Marion F. Gruber: International AIDS Vaccine Initiative (IAVI)
Beate Kampmann: London School of Hygiene & Tropical Medicine (LSHTM) Keppel Street
Diadié Maïga: World Health Organization (WHO) - Regional Office for Africa, Cité du Djoué
Marcela F. Pasetti: Center for Vaccine Development, University of Maryland School of Medicine
Stanley A. Plotkin: University of Pennsylvania
Alexander Precioso: Instituto Butantan1500, Vital Brasil Avenue
Liya Wassie: Armauer Hansen Research Institute, Jimma Road, ALERT Campus
Frederick Wittke: MSD, The Circle 66
David C. Kaslow: PATH 2201 Westlake Avenue

DOI: https://doi.org/10.1038/s41541-024-00872-6
Journal volume & issue: Vol. 9, no. 1
pp. 1 – 9

Abstract

Read online

On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including developers, manufacturers, regulators, public health officials and policy-makers from 17 countries, including 7 LMIC’s.

Published in npj Vaccines

ISSN: 2059-0105 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.nature.com/npjvaccines/

About the journal